Using FFAR2-deficient mice (Gpr43−/−), Maslowski et al. (2009) demonstrated that acetate derived from gut microbiota reduced inflammation in mouse models of arthritis, colitis, and asthma. The gene discussed is FFAR2; the disease is arthritic joint disease.